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Saturated fatty acids (FA) exert adverse health
effects and aremore likely to cause insulin resistance
and type 2 diabetes than unsaturated FA, some of
which exert protective and beneficial effects. Satu-
rated FA, but not unsaturated FA, activate Jun
N-terminal kinase (JNK), which has been linked to
obesity and insulin resistance in mice and humans.
However, it is unknown how saturated and unsatu-
rated FA are discriminated. We now demonstrate
that saturated FA activate JNK and inhibit insulin
signaling through c-Src activation. FA alter the mem-
brane distribution of c-Src, causing it to partition into
intracellular membrane subdomains, where it likely
becomes activated. Conversely, unsaturated FA
with known beneficial effects on glucosemetabolism
prevent c-Src membrane partitioning and activation,
which are dependent on its myristoylation, and block
JNK activation. Consumption of a diabetogenic high-
fat diet causes the partitioning and activation of
c-Src within detergent insoluble membrane subdo-
mains of murine adipocytes.
INTRODUCTION
Insulin resistance is a pathophysiologic condition caused by
defective insulin signaling that can cause type 2 diabetes.
Although insulin resistance has a strong genetic component
(Kahn et al., 1996), it can be initiated and exacerbated by obesity
(Ford et al., 1997). Obesity is also associated with low-grade
chronic inflammation (Hotamisligil, 2010), whose hallmarks
include enhanced production of inflammatory mediators, infiltra-
tion of activated macrophages into adipose tissue, and chronic
JNK activation in liver, muscle, and fat tissue of obese indi-
viduals (Gregor et al., 2009) and experimental animals (Hirosumi
et al., 2002; Solinas et al., 2006). Mouse studies identified
adipocytes as an important cell type within which JNK activa-
tion causes cell-autonomous interference with insulin signaling(Sabio et al., 2008). Adipocytes store fat and exert both protec-
tive and adverse effects on glucose metabolism, depending on
the quality and quantity of stored lipids (Virtue and Vidal-Puig,
2008). Not all lipids are equal in their metabolic and health
effects; whereas saturated FA have a strong diabetogenic effect
(Clandinin et al., 1991) and lead to JNK activation (Solinas
et al., 2006), certain unsaturated FA and especially polyunsatu-
rated FA (PUFA) are protective and can even reverse obesity-
induced insulin resistance (Clandinin et al., 1991; Robinson
et al., 2007; Storlien et al., 1987).
The JNKs belong to the mitogen-activated protein kinase
(MAPK) group and are activated by physical stresses, such as
UV light and heat shock, and receptor-mediated mechanisms,
including TNF receptor 1 (TNFR1) and Toll-like receptors (TLR)
2 and 4 (Karin and Gallagher, 2005). Following activation, JNKs
participate in many physiological and pathophysiological
processes, including apoptosis, cell proliferation, cell migration,
and cytokine production. Many of these effects depend on tran-
scription factor activation, but JNKs also affect cell physiology
through other substrates (Karin and Gallagher, 2005). For
instance, JNKs phosphorylate insulin receptor substrates (IRS)
1 and 2 at serine (Ser) or threonine (Thr) residues and thereby
attenuate their insulin-induced tyrosine (Tyr) phosphorylation,
resulting in downmodulation of insulin action and diminished
AKT activation (Aguirre et al., 2002; Solinas et al., 2006). JNK1-
deficient mice are protected from obesity-induced insulin
resistance (Hirosumi et al., 2002) due to loss of cell-autonomous
IRS1/2 phosphorylation within adipocytes (Sabio et al., 2008).
JNKs also contribute to insulin resistance by stimulating
production of inflammatory mediators by myeloid cells (Solinas
et al., 2007; Vallerie et al., 2008) and have neuronal effects
that influence obesity and energy metabolism (Sabio et al.,
2010). Several mechanisms were proposed to explain chronic
JNK activation in obesity, including endoplasmic reticulum
(ER) stress (Ozcan et al., 2004) and signaling through inflam-
mation-associated receptors (Shi et al., 2006; Uysal et al.,
1997). However, how obesity triggers ER stress remains to
be determined and the mechanisms by which ER stress leads
to JNK activation are not fully understood either, although
they were proposed to depend on the RNA-dependent protein
kinase PKR or TRAF2 (Hotamisligil, 2010). Other studies haveCell 147, 173–184, September 30, 2011 ª2011 Elsevier Inc. 173
implicated the phosphoinositide 3-kinase (PI3K) p85a regulatory
subunit (Taniguchi et al., 2007), the scaffolding protein JIP1
(Jaeschke et al., 2004), the lipid chaperone aP2 (Erbay et al.,
2009), and the mixed lineage kinase MLK3 (Jaeschke and Davis,
2007). These studies, too, poorly explain JNK activation in fat
depots during obesity.
In cultured cells, saturated FA such as palmitic acid (PA;
C16:0) and stearic acid (SA; C18:0), which are elevated in plasma
of obese individuals (Reaven et al., 1988), cause a spectrum of
diabetes-related defects and activate JNK (Kharroubi et al.,
2004; Solinas et al., 2006). Strong JNK activation is unique to
long-chain saturated FA, whereas unsaturated FA are poor
JNK activators and even inhibit JNK activation by saturated
FA. These effects correlate with the pathophysiological effects
of different FA types, suggesting that saturated FAmay be phys-
iologically relevant JNK activators. The exact mechanism
through which saturated FA activate JNK in cells is unknown,
although several studies suggest that FA may activate JNK via
TLR2/4 (Shi et al., 2006; Tsukumo et al., 2007). Yet, JNK activa-
tion by PA does not require TAK1, a MAPK kinase kinase
(MAP3K) that is essential for JNK activation by conventional
TLR2/4 ligands (Jaeschke and Davis, 2007; Tseng et al., 2010).
Moreover, saturated FA cause slow and sustained JNK activa-
tion, whereas JNK activation by TLR ligands is rapid and tran-
sient (Solinas et al., 2006; Tseng et al., 2010). The mechanism
responsible for discrimination between saturated and unsatu-
rated FA (some of which differ only by two hydrogen atoms)
that accounts for their different effects on JNK activity and insulin
signaling is even more mysterious.
Because FA incorporate into cellular membranes either in their
original form or after conversion into other lipid species, they
may exert receptor-independent effects on cell signaling and
physiology. For instance, PA incorporation reduces membrane
fluidity, whereas unsaturated FA and especially PUFA do not
have such an effect (Clamp et al., 1997; Karnovsky et al., 1982;
Luo et al., 1996; Rintoul et al., 1978; Stulnig et al., 1998, 2001;
Webb et al., 2000). We therefore postulated that the membrane
may play a key role in JNK regulation by FA and searched for
membrane-associated protein kinases that are essential for
JNK activation by saturated FA. We now show that a key medi-
ator of JNK activation by saturated FA is c-Src, whose activation
correlates with its FA-induced partitioning into intracellular
membrane subdomains that can be isolated based on detergent
insolubility (Karnovsky et al., 1982; Lingwood and Simons, 2007;
Pike, 2004, 2009) or visualized by fluorescent microscopy. Our
results provide a biochemical model that explains the differential
effects of saturated and unsaturated FA on JNK activity and
human health.
RESULTS
c-Src Is Required for JNK Activation by FA
Saturated FA that increase membrane order and melting
temperature lead to JNK activation, whereas unsaturated FA
capable of decreasing membrane order and melting tempera-
ture do not (Solinas et al., 2006). Optimal JNK activation by FA
requires prolonged incubation periods and is much slower than
receptor-mediated responses. We therefore hypothesized that174 Cell 147, 173–184, September 30, 2011 ª2011 Elsevier Inc.the membrane is the most proximal sensor of FA and that
membrane alterations may activate an associated protein kinase
that triggers a signaling cascade leading to JNK. Although MLK3
was identified as the most upstream protein kinase that medi-
ates JNK activation by saturated FA (Jaeschke and Davis,
2007), it is a MAP3K that is not membrane associated (Handley
et al., 2007). BecausemanyMAP3Ks act downstream to tyrosine
kinases, we tested whether the Src group of membrane-
anchored tyrosine kinases is involved in JNK activation by FA.
Indeed, immortalized fibroblasts derived from mice that are
deficient in three broadly expressed Src kinases—c-Src, Yes,
and Fyn (or SYF) (Stein et al., 1994) —did not exhibit increased
JNK1 activity upon incubation with either SA or PA (Figure 1A).
A similar defect was exhibited by c-Src/ fibroblasts, and
reconstitution of SYF/ cells with c-Src (SYF+Src) fully restored
JNK1 activation. By contrast, reconstitution of SYF/ cells with
Yes or Fyn did not fully restore JNK activation by saturated FA
(Figure 1B). c-Src was mainly required for JNK activation by
saturated FA with acyl chains of at least 16 carbons, as lauric
acid (LA; C12:0) and myristic acid (MA; C14:0) did not activate
JNK in SYF+Src cells, and neither did the monounsaturated
FA palmitoleic acid (POA; C16:1, n-7) or the PUFA eicosapentae-
noic acid (EPA; C20:5, n-3) (Figure S1A available online). Knock-
down of endogenous c-Src by shRNA in NIH 3T3 cells
decreased JNK activation by PA (Figure 1C), and similar results
were obtained in human HEK293T cells (Figure S1B). JNK
activation by PA was restored by reconstitution of Src-deficient
cells with wild-type (WT) Src, but not with an inactive (Y418F)
mutant (Figure 1D). SYF –/– cells reconstituted with c-Src(Y527F),
lacking the negative phosphorylation site recognized by Csk
(Okada et al., 1991), displayed modestly enhanced JNK activa-
tion in response to PA, ruling out involvement of Csk-mediated
c-Src phosphorylation in the response to saturated FA. By
contrast, a compound c-Src(Y527F/G2A) mutant that also
lacks the myristoylation sequence necessary for membrane
targeting (Patwardhan andResh, 2010) was highly compromised
in JNK activation (Figures 1D and S1C). Pretreatment of
SYF+Src cells with the Src family kinase inhibitor PP2 prevented
JNK activation by PA, but the structurally similar control
compound PP3 was ineffective (Figure S1D).
We also examined the role of c-Src in PA-induced MLK3
activation. NIH 3T3, SYF, and SYF+Src cells were treated with
PA for up to 8 hr, and MLK3 activation was assessed by immu-
noblotting with an antibody that recognizes Thr277/Ser281
phosphorylation. Within 2 hr of PA addition, sustained MLK3
phosphorylation was detected in NIH 3T3 and SYF+Src cells,
but not in SYF/ cells (Figure 1E). JNK activation in the same
cells was also monitored by immunoblotting and was found to
parallel MLK3 activation. Curiously, SYF/ cells contained
lower amounts of MLK3 than 3T3 or SYF+Src cells, but the basis
and significance of this finding are unclear.
We examined whether c-Src is needed for induction of ER
stress, evaluated by induction of CHOP mRNA and IRE1a-cata-
lyzed XBP1 mRNA splicing. Incubation of fibroblasts with either
PA or SA inducedCHOPmRNA and XBP1mRNA splicing, but no
role for Src kinases could be identified (Figure S1E). In accor-
dance with these results, PP2 pretreatment of J774A.1 cells
did not block PA-induced ER stress markers (Figure S1F). PP2,
Figure 1. c-Src Is Required for JNK Activation and Insulin Resistance by Saturated FA
(A–D) JNK activation by FAs is c-Src dependent.
(A) NIH 3T3, Src/, SYF /, and SYF fibroblasts reconstituted with c-Src were treated for 6 hr with 500 mM palmitic (PA) or stearic (SA) acids loaded onto BSA.
Whole-cell lysates were prepared and subjected to JNK1 immunecomplex kinase assay using GST-c-Jun (1–79) as a substrate and immunoblotting with
indicated antibodies.
(B) NIH 3T3 and SYF / fibroblasts transduced with empty vector, Fyn, or Yes expression vectors were treated with SA or PA and analyzed as above.
(C) NIH 3T3 cells were infected with lentiviral constructs carrying scrambled (Scr) or c-Src-specific shRNAs. After selection in puromycin-containing medium,
cells were treated with PA, and JNK1 activity and c-Src expression were analyzed.
(D) NIH 3T3, Src/ cells, and Src/ cells transduced with empty vector or WT c-Src or c-Src(Y418F) expression vectors or SYF / cells reconstituted with WT,
Y527F, or Y527F/G2A c-Src vectors were treated with PA-loaded BSA or BSA alone and analyzed as above. Fold increase in JNK1 activity is shown below and
was determined by densitometric analysis of three similar but separate experiments.
(E) Src is required for MLK3 activation by PA. NIH 3T3, SYF /, and SYF+Src cells were treated with PA-loaded BSA for the indicated time periods. Cell lysates
were prepared, and phosphorylation of MLK3 and JNK1/2 was monitored by immunoblotting.
(F) PA-induced insulin resistance is c-Src dependent. NIH 3T3, SYF /, and SYF+Src cells were pretreated with or without PA for 6 hr before treatment with
100 ng/ml insulin for 7.5 and 15 min. JNK activation and insulin-induced AKT phosphorylation were analyzed by immunoblotting.
See also Figure S1.however, inhibited JNK activation and induction of TNF produc-
tion in PA-incubated J774A.1 macrophages (Figure S1G and
S1H). Importantly, in SYF/ cells, PA treatment failed to inhibit
insulin-induced AKT activation, but reconstitution with c-Src
restored PA-induced inhibition of AKT Ser473 phosphorylationto the same magnitude seen in 3T3 fibroblasts (Figure 1F).
c-Src expression also restored PA-induced JNK1/2 phosphory-
lation. Collectively, these results establish a critical role for c-Src
in JNK activation by FA and inhibition of insulin-mediated AKT
activation.Cell 147, 173–184, September 30, 2011 ª2011 Elsevier Inc. 175
Saturated FA Induce Src Partitioning into
Detergent-Insoluble Membrane Microdomains
Next, we examined whether c-Src activation is linked to changes
in membrane structure. Membrane microdomains enriched in
cholesterol, sphingolipids, and other lipids with saturated acyl
chains, which presumably reducemembrane fluidity, can be iso-
lated based on resistance to solubilization with cold nonionic
detergents (Pike, 2009). Such membrane microdomains, some-
times referred to as lipid rafts, are postulated to be enriched in
signaling proteins that can coalesce into larger assemblies
(Janes et al., 1999; Pike, 2009). To examine whether saturated
FA alter the membrane distribution of c-Src, SYF+Src cells
were treated with PA, SA, or BSA alone for 4 hr before prepara-
tion of lysates that were solubilized with Triton X-100 at 4C.
Detergent-resistant membranes (DRMs) were isolated by equi-
librium density gradient centrifugation (Lingwood and Simons,
2007). Using this technique, DRMs and their associated proteins
float to the gradient’s top (fraction 1), whereas solubilized
membranes and cell debris remain in fraction 4 (Figure 2A). In
BSA-treated cells, very little c-Src was present in the DRM frac-
tion (fraction 1), and most of it was in fractions 3 and 4. However,
upon incubation with PA- or SA-loaded BSA, the distribution of
c-Src had significantly changed, and a substantial amount of
the protein was in fraction 1 (Figures 2A and 2B). A similar enrich-
ment within fraction 1 of cells treated with PA or SA was seen for
c-Src phosphorylated at Tyr418, presumably an activated form
of the kinase. Fraction 1 also contained flotillin-1 and flotillin-2,
proteins that serve as DRMmarkers, but was devoid of calnexin,
a membrane protein that is excluded from DRM (Lingwood and
Simons, 2007). Unlike c-Src, the amounts of flotillin-1/2 within
fraction 1 were not affected by incubation with either PA or SA
(Figure 2B). Incubation with PA-loaded BSA also increased the
amounts of JNK1/2, MLK3, and MKK4 within fraction 1 (Figures
2A and 2B). However, no significant effect on the distribution
of p85 PI3K, a protein suggested to be involved in JNK activation
and insulin resistance (Taniguchi et al., 2007), was seen (Fig-
ure 2B). Immunecomplex kinase assay with enolase as a sub-
strate confirmed that incubation of cells with PA or SA increased
the amount of active c-Src within fraction 1 (Figure 2C). PA treat-
ment also enhanced the amount of Yes, but not Fyn, within
fraction 1, but the effect on Yes was more subtle than the effect
on c-Src (Figures S2A and S2B). The nonmyristoylated
c-Src(G2A) mutant was mostly confined to the soluble fraction
4 and did not shift into the DRM fraction after PA treatment
(Figures S2C). c-Src(G2A) also exhibited less Tyr418 phosphor-
ylation before and after PA treatment. In contrast, a dually palmi-
toylated c-Src(S3C/S6C) mutant (Sandilands et al., 2007) was
present within the DRM fraction and was Tyr418 phosphorylated
even in BSA-treated cells, and PA treatment led to only a modest
increase in its amount in fraction 1 relative to fraction 4 (Figures
S2D). Consistent with their poor effect on JNK activity (Fig-
ure S1A), MA treatment led to a small increase in c-Src within
the DRM fraction, and LA had no effect on the membrane distri-
bution of c-Src (Figure 2D). Likewise, MA and LA were poorer
inducers of CHOPmRNA in response to PA and did not stimulate
XBP1 mRNA splicing (Figure 2E).
We also used a detergent-independent technique for isolation
of putative lipid rafts that relies on physical disruption of cellular176 Cell 147, 173–184, September 30, 2011 ª2011 Elsevier Inc.membranes in the presence of basic sodium carbonate buffer
(Ostrom and Insel, 2006). This procedure yielded similar results
to those described above, demonstrating PA-induced accumu-
lation of c-Src and phospho-Tyr418 c-Src within the presumed
lipid raft fraction, although enrichment of phospho-Tyr418
c-Src was more pronounced relative to the more modest enrich-
ment of c-Src (Figures S2E and S2F). Compared to Triton X-100,
a strong detergent that tends to solubilize all but the most
ordered membrane subdomains, detergent-independent lipid
raft isolation tends to yield larger membrane fragments that
include highly ordered (and Triton X-100-insoluble) and less-
ordered microdomains (Pike, 2004). Our results may therefore
suggest that c-Src activation occurs within less-ordered micro-
domains, and once c-Src is activated, it is concentrated within
amoreorderedmembranecompartment. An in vitro kinaseassay
using a peptide substrate demonstrated that the c-Src that
segregated within the putative lipid raft fraction generated by
the detergent-independent method was activated if isolated
from PA-treated cells (Figures S2G). PA treatment led to no
change in c-Srcactivitywithin raft-devoid fractions (FiguresS2H).
Unsaturated FA Inhibit Src Redistribution and Activation
Mono- and polyunsaturated FA increase membrane fluidity
(Clamp et al., 1997; Karnovsky et al., 1982; Luo et al., 1996; Stul-
nig et al., 1998, 2001; Webb et al., 2000) and antagonize cellular
effects of saturated FA (Akazawa et al., 2010). We pretreated
SYF+Src cells with 300 mM of the monounsaturated POA or
the PUFA EPA for 15 min prior to treatment with PA and exam-
ined c-Src membrane distribution and activity, JNK activation,
and ER stress markers. Pretreatment with either POA or EPA
blocked PA-induced partitioning of total c-Src and phospho-
Tyr418 c-Src into the DRM fraction while having little to no effect
on flotillin-1/2 and calnexin distribution (Figures 3A and 3B).
However, pretreatment with 300 mM SA did not prevent PA-
induced c-Src redistribution, and as expected, even at this lower
concentration, SA caused a small amount of c-Src redistribution
on its own (Figure S3A). POA and EPA pretreatment also blocked
PA-induced JNK activation (Figure 3C) as well as induction of ER
stress markers by PA (Figure 3D). These results indicate that
mono- and polyunsaturated FA block the effects of saturated
FA on c-Src membrane distribution and activity, JNK activation,
and ER stress. Given the opposing effects of unsaturated FA
versus saturated FA on membrane fluidity, these findings
support the hypothesis that altered membrane fluidity is key to
the signaling effects of saturated FA.
To determine whether saturated FA are preferentially incorpo-
rated into DRM, we treated cells for 2 hr with a mixture of
3H-labeled and cold PA, isolated DRMs by the detergent-depen-
dent method, and measured radioactivity in the different frac-
tions. Most of the radioactivity was present in the DRM fraction
(Figure 4A), especially when normalized to the protein content
of each fraction (Figure 4B). To examine whether unsaturated
FA incorporate preferentially into the detergent-soluble mem-
brane fraction, we incubated cells with 3H-labeled oleic acid
(OA; C18:1). Most of the 3H-OA-derived radioactivity was
present in the soluble fraction 4 (Figures 4C and 4D). When
cells were pretreated with POA and EPA prior to incubation
with 3H-PA, incorporation of 3H-PA-derived radioactivity into
Figure 2. Saturated FA Induce c-Src Segregation into Detergent-Resistant Membranes
(A) SYF+Src cells were treated for 4 hr with BSA alone or PA- or SA-loaded BSA. Whole-cell lysates were solubilized with Triton X-100 at 4C, and DRMs were
isolated by equilibrium density gradient centrifugation. Fractions were collected from the gradient’s top, such that fraction 1 represents the DRM fraction.
Presence of the indicated proteins and phospho-Tyr418 c-Src in the different fractions was analyzed by immunoblotting. Flotillin-1 and flotillin-2 are lipid raft
markers, whereas calnexin is a membrane protein that is excluded from lipid rafts/DRM. The percentage of c-Src in Fr. 1 is indicated underneath and was
calculated by densitometric analysis of four separate experiments.
(B) FA-induced enrichment of different signaling proteins in the DRM fraction following PA or SA treatments. Results are averages ± SD of three to five exper-
iments similar to the one in (A). *p < 0.05.
(C) c-Src kinase activity in different membrane fractions from cells treated with BSA or BSA plus saturated FA. Cells were treated and their membranes were
fractionated as in (A). c-Src was immunoprecipitated from the different fractions and its activity measured using acid-activated enolase as a substrate. Average
fold increase in c-Src activity (n = 4 for PA; n = 3 for SA) is indicated below.
(D) c-Src membrane redistribution is dependent on FA acyl chain length. SYF+Src cells were treated with 500 mMPA (C16), MA (C14), or LA (C12). The cells were
fractionated as in (A), and the fractions were immunoblotted for the indicated proteins.
(E) SYF+Src cells were treated for 6 hr with either BSA alone or BSA loaded with PA, MA, or LA. Induction of CHOP mRNA or XBP1 mRNA splicing was analyzed
by Q-RT-PCR. Results are averages ± SD. n = 3.
See also Figure S2.
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Figure 3. Mono- and Polyunsaturated FA Block c-SrcMembrane Redistribution and Activation as well as JNK Activation and Induction of ER
Stress Markers
(A–D) Unsaturated FA inhibit c-Src segregation and activation within DRM in response to PA. SYF+Src cells were pretreated with either monounsaturated
palmitoleic acid (POA) (A) or polyunsaturated eicosapentaenoic acid (EPA) (B) for 15 min prior to addition of BSA or BSA loaded with PA. After 4 hr, membranes
were solubilized and fractionated as in Figure 2, and distribution of the indicated proteins was determined by immunoblotting. c-Src and phospho-Tyr418 c-Src
accumulated in the DRM fraction of PA-treated cells, and this was prevented by pretreatmentwith either POA (A) or EPA (B). (C) JNK activation and (D) induction of
ER stress markers in the cells subjected to the above treatments were assessed as described in Figures 1 and 2. See also Figure S3.the DRM fraction was significantly reduced (Figure 4E). In
contrast, pretreatment with SA did not inhibit incorporation of
3H-PA into the DRM fraction. OA behaved similarly to POA and
EPA in that it blocked c-Src partitioning into the DRM fraction
in response to PA (Figure S3B) and prevented PA-induced ER
stress (Figure S3C) and JNK activation (Figure S3D). These
results suggest that exposure of cells to PA results in direct
effects on membrane structure, which eventually affect the
distribution and activity of membrane-anchored c-Src.
DRMand SrcActivation in Adipose Tissue ofObeseMice
Next, we checked whether consumption of high-fat diet (HFD)
also results in c-Src partitioning and activation within DRM mi-
crodomains. C57BL/6 mice were placed on HFD for 16 weeks,
and their brown adipose tissues (BAT) and white adipose tissues
(WAT) were collected. The distribution of membrane proteins,
including c-Src, within these tissues was analyzed by the Triton
X-100 method described above. Consumption of HFD, but not
normal chow (low-fat diet [LFD]), resulted in a dramatic increase
of total c-Src and phospho-Tyr418 c-Src within fraction 1 of
Triton X-100-solubilized BAT (Figure 5A). Consumption of HFD
also increased the amounts of flotillin-1/2 within DRMs, suggest-
ing a major expansion of such membrane microdomains in BAT,
but as expected, calnexin remained excluded from the DRM
fraction. Consumption of HFD also increased JNK1/2 and
MLK3 within the DRM fraction but had little effect on the distribu-
tion of MKK4 and the p85a subunit of PI3K (Figure 5A). A Src
kinase assay confirmed that HFD consumption resulted in
c-Src activation and induced a large increase in the amount of
activated Src within fraction 1 (Figure 5B).178 Cell 147, 173–184, September 30, 2011 ª2011 Elsevier Inc.Similar results were obtained by analysis of WAT. Although
HFD consumption did not lead to an expansion of the DRM frac-
tion, as indicated by the nearly identical distribution of flotillin-1/2
in membrane fractions of WAT from lean and obese mice, the
amount of phospho-Tyr418 Src was higher in fraction 1 of WAT
membranes isolated from obese mice (Figure 5C). Immunecom-
plex kinase assay using enolase as a substrate confirmed that
there was a clear and significant increase in the amount of
c-Src and c-Src catalytic activity in the DRM fraction of WAT
from obese mice (Figure 5D). As expected, HFD consumption
resulted in JNK1 activation in both BAT and WAT (Figures S4A
and S4B). Increased JNK activation was accompanied by
decreased AKT Ser 473 phosphorylation (Figures S4A and S4B).
Dasatinib (Sprycel) is a broad spectrum kinase inhibitor
that potently inhibits c-Src (Agostino et al., 2010). Dasatinib is
used for treatment of Imatinib-resistant chronic myelogenous
leukemia (CML), but several case reports indicated that it had
beneficial effects on blood glucose in diabetic patients with
CML (Agostino et al., 2010; Breccia et al., 2008). We examined
whether dasatinib improves glucose tolerance in mice rendered
obese by feeding with a HFD for 16 weeks. Indeed, 3 hr of treat-
ment with 30 mg/kg dasatinib resulted in improved glucose
tolerance in obese mice (Figure S5). However, given the ability
of dasatinib to inhibit several different tyrosine kinases, including
the entire Src family, it is difficult to attribute this effect to c-Src
itself.
Subcellular Distribution of c-Src after FA Treatment
Detergent-dependent and -independent methods of DRM or
lipid raft isolation are informative but provide no direct evidence
Figure 4. Saturated FA Are Preferentially Incorpo-
rated into DRM
(A and B) SYF+Src cells were treated for 2 hr with 200 mM
3H-labeled PA and 300 mM cold PA loaded onto BSA. Cell
lysates were prepared and membranes were solubilized
and fractionated as in Figure 2. (A) The amount of 3H in
each fraction was determined by scintillation counting and
(B) normalized to protein content. Results are averages ±
SD. n = 3.
(C and D) SYF+Src cells were treated for 2 hr with 110 nM
3H-labeled OA and 300 mM cold OA loaded onto BSA.
Cells were fractionated as above, and (C) the amount of 3H
in each fraction was determined by scintillation counting
and (D) normalized to protein content. Results are aver-
ages ± SD. n = 3.
(E) SYF+Src cells were pretreated for 15 min with 300 mM
EPA, POA, or SA, followed by a 2 hr incubation with
200 mM 3H-labeled PA and 300 mM cold PA loaded onto
BSA. Cell lysates were solubilized and fractionated, and
the relative amount of 3H in fraction 1 was determined as
above. Results are averages ± SD. n = 3; *p < 0.05.
See also Figure S3.that the distribution of the protein in question within the mem-
brane has changed prior to membrane solubilization and extrac-
tion. Furthermore, the membrane fractionation approach pro-
vides no information regarding the subcellular distribution of
the protein in question. Previous studies of c-Src activation
have demonstrated that c-Src is frequently targeted to ill-defined
endosomal structures distinct from the plasma membrane
(Sandilands et al., 2004; Seong et al., 2009; Wang et al., 2005).
Furthermore, the lipid raft markers flotillin-1 and flotillin-2 are
frequently found on organelles and endosomal membranes in
addition to the plasma membrane (Browman et al., 2007; Rajen-
dran et al., 2007). We used indirect three-color immunofluores-
cence and confocal microscopy to track the distribution of phos-
pho-Tyr418 c-Src before and after treatment with PA or PA+POA
relative to that of flotillin-1 and the lysosomal marker LAMP-1.
The results indicated that, after 2.5 hr treatment with PA,Cell 147, 173–1Tyr418-phosphorylated c-Src was present in
aggregates associated with perinuclear and
vesicular membranes (Figure 6A). Phospho-
Tyr418 c-Src aggregates frequently presented
as distended rings, which were infrequent in
BSA-treated control cells, or cells that were
pretreated with POA prior to addition of PA.
Flotillin-1 and LAMP-1 strongly colocalized
both in control cells and in PA-treated cells.
However, phospho-Tyr418 c-Src in control cells
exhibited only weak colocalization with flotillin-1
or LAMP-1; but upon PA treatment, colocaliza-
tion of phospho-Tyr418 c-Src with flotillin-1
and LAMP-1was strongly enhanced (Figure 6A).
POA pretreatment inhibited PA-induced coloc-
alization of activated c-Src with flotillin-1 or
LAMP-1 but had no effect on the relative distri-
bution of the two markers.
To confirm these results, we used a deter-
gent-independent postnuclear cell fractionationprocedure and collected a fraction that was enriched for LAMP-1
(fraction 3) (Figure S6) and subjected it to lipid raft analysis using
Triton X-100. This analysis indicated that the DRM fraction of the
lysosomal membrane was strongly enriched for c-Src and phos-
pho-Tyr418 c-Src after PA treatment (Figure 6B). However, only
a small amount of c-Src and phospho-Tyr418 c-Src was present
in fraction 1 of BSA-treated cells or cells preincubated with POA
prior to PA addition. Consistent with the strong colocalization of
LAMP-1 and flotillin-1 revealed by the immunofluorescence
analysis, the DRM fraction of the lysosomal membrane con-
tained both LAMP-1 and flotillin-1 (Figure 6B).
DISCUSSION
JNK activity is elevated in adipocytes of obese individuals
(Gregor et al., 2009) and mice (Hirosumi et al., 2002; Solinas84, September 30, 2011 ª2011 Elsevier Inc. 179
Figure 5. Consumption of High-Fat Diet Results in c-Src Segregation and Activation within DRM of Adipose Tissue
(A–D) Mice were kept on normal chow (LFD) or high-fat diet (HFD) for 16 weeks, after which brown (A and B, BAT) and white (C and D, WAT) adipose tissues were
isolated. The tissues were homogenized, excess lipid was removed, and the lysates were adjusted to equal protein concentrations before cold Triton X-100
solubilization and fractionation as in Figure 2.
(A) Density gradient fractions of BAT membranes were analyzed for the indicated proteins by immunoblotting. Results show two different mice for each dietary
condition and are representative of separate experiments in which three mice were analyzed.
(B) c-Src was immunoprecipitated from the gradient fractions of BAT isolated from mice LFD2 and HFD2, and its kinase activity was measured using enolase as
a substrate.
(C) Density gradient fractions of WAT membranes from the indicated mice were analyzed for the indicated proteins by immunoblotting.
(D) c-Src was immunoprecipitated from fraction 1 of three different LFD- or HFD-fed mice, and its kinase activity was measured as above.
See also Figures S4 and S5.et al., 2006). Chronic JNK activation is of physiological signifi-
cance, as it contributes to insulin resistance, obesity, and
production of inflammatory cytokines (Hirosumi et al., 2002; Sa-
bio et al., 2010; Solinas et al., 2007). The exact mediators by
which obesity activates JNK are unknown, but saturated FA
such as PA and SA are potent JNK activators in cultured cells,
whereas unsaturated FA have only a marginal effect (Solinas
et al., 2006). In fact, some unsaturated FA, including POA, which
differs from PA by only two hydrogens, and especially PUFA,
inhibit JNK activation by saturated FA. Such observations invoke
the existence of a sensor that discriminates between saturated
and unsaturated FA, at times detecting the presence of a single
double bond or the absence of two hydrogen atoms. Our results
suggest that this sensor/receptor is none else but the
membrane. Incorporation of saturated FA, whose acyl chains
assume a rigid and straight conformation, into cellular
membranes increases membrane order, resulting in reduced
fluidity and higher melting temperature (Karnovsky et al., 1982).
By contrast, the bent tails of unsaturated FA reduce membrane
order and increase fluidity. We now show that saturated FA stim-
ulate c-Src partitioning into membrane subdomains with
increased rigidity that can be isolated based on resistance to
detergent solubilization or increased density and that the c-Src
that resides within such microdomains is more active than the
general pool of c-Src. We also provide genetic evidence that180 Cell 147, 173–184, September 30, 2011 ª2011 Elsevier Inc.c-Src is required for FA-induced JNK1 and MLK3 activation.
Furthermore, mono- and polyunsaturated FA, POA, and EPA,
respectively, do not alter the membrane distribution of c-Src
on their own and block its partitioning and activation within
DRMs in cells treated with PA. Correspondingly, POA and EPA
prevent JNK activation by PA.
Although these results do not exclude the existence of a pro-
tein receptor that can discriminate between different FA forms,
they favor a hypothetical model according to which FA discrim-
ination is carried out by the membrane. In addition to decreasing
membrane fluidity, saturated FA expand the lipid raft compart-
ment, defined as a region of the membrane with decreased
fluidity and resistance to nonionic detergents due to enrichment
with cholesterol, sphingolipids, and saturated phospholipids
(Pike, 2009). By contrast, membrane supplementation with un-
saturated FA decreases lipid raft formation (Clamp et al., 1997;
Karnovsky et al., 1982; Stulnig et al., 1998, 2001). Although
the in vivo existence of lipid rafts remains controversial, such
experiments suggest that saturated and unsaturated FA have
opposing effects on membrane fluidity and/or structure that
result in differential susceptibility to solubilization with nonionic
detergents. It was also noted that cellular membranes from
obese individuals have abnormal composition and decreased
fluidity (Faloia et al., 1999; Watala and Winocour, 1992).
Yet, the pathophysiological implications of these observations
Figure 6. Subcellular Localization and Redistribution of Activated c-Src in FA-Treated Fibroblasts
(A) SYF+Src cells were treated for 2.5 hr with BSA, PA, or PA+POA before fixation and staining with antibodies to phospho-Tyr418 c-Src, LAMP-1, or flotillin-1.
Three-color confocal images were acquired on a Leica SPE-2 confocal microscope. Magnification, 633. Arrows indicate aggregates of phospho-Tyr418 c-Src
that colocalize with flotillin-1 and LAMP-1.
(B) SYF+Src cells were treated as above. Cells were lysed in detergent-free buffer, and postnuclear lysates were separated on a Percoll gradient under
high-speed centrifugation. A band enriched for LAMP-1 was collected, immediately resuspended in buffer, and solubilized with Triton X-100 at 4C and then
fractionated on density gradients. Fractions were collected and examined for the indicated proteins by immunoblotting.
See also Figure S6.remained unclear, and no direct effects on signaling proteins that
lead to insulin resistance were found.
c-Src is a myristoylated protein that can be found both within
and outside of lipid rafts, as well as within endosomes, before
translocating to the plasma membrane (Arcaro et al., 2007; Mu-
kherjee et al., 2003; Sandilands et al., 2004; Seong et al., 2009).
c-Src can be activated within all of the aforementioned com-
partments, including rapid activation at nonraft regions of theplasma membrane and slower activation within putative lipid
rafts (Seong et al., 2009). Activation can also occur within endo-
somes that transit from the perinuclear region to the plasma
membrane (Sandilands et al., 2004). Obviously, c-Src distribu-
tion within cellular membranes is dynamic and is modulated
by environmental conditions. Our results demonstrate that incu-
bation of fibroblasts with PA increases the amount of c-Src that
is present within the DRM fraction or membrane microdomainsCell 147, 173–184, September 30, 2011 ª2011 Elsevier Inc. 181
of increased density that can be isolated by a detergent-free
method. Imaging studies confirm that PA induces clustering
of Tyr-418 c-Src within endosomal and lysosomal membranes.
However, it is unclear whether c-Src translocates to spe-
cific membrane microdomains before or after its activation.
Nonetheless, given the presumed higher protein density of the
c-Src-containing microdomains, it is plausible that increased
molecular crowding facilitates c-Src autophosphorylation and
activation. Enrichment of c-Src within DRM was also seen in
BAT and, to a lesser extent, in WAT of mice kept on HFD. It is
plausible that BSA and other FA-binding proteins are taken up
by the cell via a pinocytotic mechanism and thereby deliver satu-
rated FA to the same intracellular endosomal and lysosomal
compartments within which PA-induced c-Src activation has
been observed.
Treatment of fibroblasts with PA also results in JNK1/2 and
MLK3 recruitment to DRM. JNK1/2 were previously suggested
to associate with lipid rafts in response to reactive nitrogen
species (Wu et al., 2008) or following UV-C-induced ceramide
accumulation (Charruyer et al., 2005), suggesting that such
membrane microdomains may contain proteins that serve as
platforms for formation of JNK-signaling modules. MLK3, the
MAP3K responsible for JNK activation by FA (Jaeschke and Da-
vis, 2007), is a soluble protein, and therefore its recruitment into
the DRM fraction must be mediated through interactions with
another protein, which could be either c-Src or a c-Src-binding
protein. Importantly, c-Src activity is required for MLK3 and
JNK1 activation and inhibition of insulin signaling in fibroblasts
incubated with saturated FA. Moreover, incubation of fibroblasts
with unsaturated FA prevents changes in c-Src distribution and
inhibits both c-Src and JNK activation. These findings support
the hypothesis that c-Src activation within membrane microdo-
mains of reduced fluidity is a crucial event in the JNK-signaling
cascade triggered by FA and are consistent with the model
according to which the membrane is the primary sensor of FA
structure.
Dietary n-3 PUFAs, such as EPA and docosahexaenoic acid
(DHA; 22:6, n-3), are common in fish and marine mammals (Si-
mopoulos, 2002). Epidemiological studies have shown that
consumption of large amounts of foods rich in n-3 PUFAs
reduces the incidence of type 2 diabetes and heart disease
and improves glycemic control even in the face of high body
mass index (Jørgensen et al., 2006; Kagawa et al., 1982; Kro-
mann and Green, 1980; Thorsdottir et al., 2004). Other studies
have implicated DHA, EPA, or fish oil in protection from insulin
resistance and type 2 diabetes in rodents and humans (Browning
et al., 2007; Luo et al., 1996; Neschen et al., 2007; Oh et al., 2010;
Storlien et al., 1987). Monounsaturated FA also enhance insulin
sensitivity, and POA was suggested to function as a protective
lipokine (Cao et al., 2008; Ryan et al., 2000). Mono- and polyun-
saturated FA are biologically active and have many pleiotropic
effects that could account for their antidiabetic actions, including
reduced adipose tissue inflammation (Oh et al., 2010; Todoric
et al., 2006). EPA or DHA also inhibit JNK/AP-1 activation by
various stimuli (Liu et al., 2001; Oh et al., 2010; Todoric et al.,
2006). Several hypotheses were proposed to explain the antidi-
abetic effects of mono- and polyunsaturated FA, including
altered eicosanoid production (Culp et al., 1980) and modulation182 Cell 147, 173–184, September 30, 2011 ª2011 Elsevier Inc.of peroxisome proliferator-activated receptors (Neschen et al.,
2007). In addition, unsaturated FA, but not saturated FA,
activate anti-inflammatory G protein-coupled receptors such
as GPR120 (Hirasawa et al., 2005; Oh et al., 2010). Activation
of this receptor can decrease JNK activation in response to
LPS in vitro, and GPR120-deficient mice are more insulin resis-
tant on LFD and refractory to the insulin-sensitizing effects of
PUFA. These data suggest that the anti-inflammatory activity
of poly- and monounsaturated FAs may be independent of
effects on membrane fluidity. However, involvement of
GPR120 in the ability of unsaturated FA to block JNK activation
by saturated FA has not been tested. Likewise, it is unknown
whether saturated FA can competitively prevent GPR120 activa-
tion by unsaturated FA. Such a scenario would require GPR120
or similar receptors to bind many different FAs but be activated
only by unsaturated FA. Until such a receptor is found, the
opposing effects of saturated and unsaturated FA on c-Src,
MLK3, and JNK1 activity are most parsimoniously explained
by their differential effects on membrane fluidity and structure.
Furthermore, it should be noted that the effects of saturated
FA on JNK, MLK3, and Src distribution and activity are slow,
requiring an hour or more to be detected, and therefore they
seem inconsistent with standard receptor-mediated events
that occur within much shorter time scales. The cellular uptake
of saturated FA from FA-binding proteins and subsequent FA
incorporation into biological membranes is also unlikely to be
a rapid process.EXPERIMENTAL PROCEDURES
Detailed experimental procedures are described in the Extended Experimental
Procedures. In brief, most of the in vitro experiments were conducted using
mouse fibroblasts that are wild-type, c-Src–/–, SYF–/–, or SYF–/– reconstituted
with c-Src. Fibroblasts were incubated with low-endotoxin BSA that was
delipidated and then loaded with different FA. JNK activation and phosphory-
lation were analyzed as described (Solinas et al., 2006). c-Src activation was
analyzed either by immunecomplex kinase assays or by immunochemical
detection of Tyr418 phosphorylation. Lipid rafts were isolated as previously
described (Lingwood and Simons, 2007; Ostrom and Insel, 2006). c-Src
activation and subcellular distribution were also analyzed by indirect immuno-
fluorescence of formaldehyde fixed cells. Mice were kept on low-fat or high-fat
diets as described (Solinas et al., 2007).SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at doi:10.1016/j.cell.
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